On July 9th, the Department of Justice issued subpoenas to clinics, doctors, and even drug manufacturers connected to gender-affirming care. These subpoenas appear to include private patient information. In this episode of Gender Matters: Insights from a Physician, I explain why this affects far more than transgender patients. From patient trust to access to standard treatments like puberty blockers or hormones for non-trans conditions, this action has ripple effects across healthcare. What h...
All content for Gender Matters: Insights from a Physician is the property of Dr Shannon and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
On July 9th, the Department of Justice issued subpoenas to clinics, doctors, and even drug manufacturers connected to gender-affirming care. These subpoenas appear to include private patient information. In this episode of Gender Matters: Insights from a Physician, I explain why this affects far more than transgender patients. From patient trust to access to standard treatments like puberty blockers or hormones for non-trans conditions, this action has ripple effects across healthcare. What h...
How Many Trans* Youth Retransition? Far Fewer Than You Think (73)
Gender Matters: Insights from a Physician
26 minutes
5 months ago
How Many Trans* Youth Retransition? Far Fewer Than You Think (73)
If you’ve ever wondered, “What if they change their mind?”—you’re not alone. This episode breaks down the newest data on how often trans youth stop hormone therapy and retransition to a cisgender identity. We walk through a 2025 study of over 1,000 adolescents and explore what it really tells us—about numbers, nuance, and how we think about gender-affirming care. 📚 Citation: Boskey ER, Scheffey KL, Pilcher S, et al. A Retrospective Cohort Study of Transgender Adolescents' Gender-Affirmi...
Gender Matters: Insights from a Physician
On July 9th, the Department of Justice issued subpoenas to clinics, doctors, and even drug manufacturers connected to gender-affirming care. These subpoenas appear to include private patient information. In this episode of Gender Matters: Insights from a Physician, I explain why this affects far more than transgender patients. From patient trust to access to standard treatments like puberty blockers or hormones for non-trans conditions, this action has ripple effects across healthcare. What h...
